ArticleFrontiers in microbiology2025
First identification of human adenovirus subtype 21a in Shenzhen, China with high-throughput sequencing.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human adenovirus type 21 (HAdV-21) is recognized as an important pathogen responsible for acute respiratory infections (ARIs). However, it has been rarely reported and remains poorly characterized to date in China. Outpatient or inpatient children under 14 years old with suspected ARIs were enrolled from two hospitals in Shenzhen from September 2023 to April 2024. Respiratory samples were collected and tested for 22 common respiratory pathogens. A comparative analysis was conducted on the positive proportions of pathogens among different groups. Phylogenetic analysis and amino acid mutation analysis were conducted for HAdV-21 strains. A total of 498 pediatric patients with ARIs were enrolled. There were 366 (73.5%) patients infected with at least one pathogen, and 133 (26.7%) patients co-infected with other pathogens. The most frequently detected pathogens were
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.